Cure My Disease

Don't miss your cure!

 Log in / Sign up

New program aims to stop hospital stays from robbing seniors of independence

NCT ID NCT06449053

Disease control Sponsor: Assistance Publique - Hôpitaux de Paris Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 13, 2026 · Last updated Jul 14, 2026 · Updated 1 time

Summary

This study tests a program called TAKE CARE, designed to prevent older adults (75+) from losing their ability to perform daily activities after a hospital stay. The program uses e-health tools, staff training, and environmental changes to address six common causes of hospital-related dependence. Researchers will compare outcomes in patients from 11 French hospitals who receive the program versus usual care.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
TAKE CARE intervention (e-health application, staff training, environmental adaptations)
What this could lead to
If effective, this program could reduce the risk of older adults losing their independence after a hospital stay, helping them recover better and faster.
What could go wrong
The trial is relatively small and tests a complex intervention across multiple hospitals, so results may vary. It is not a drug or cure, and success depends on consistent staff adherence.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

918 people

The number who actually took part.

Started

Feb 2025

Expected to finish

Dec 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

75 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age ≥ 75 ans * Unscheduled hospitalisation in one of the participating departments for an acute pathology, excluding post-operative care Exclusion Criteria: * Patients with a usual ADL score (assessed 15 days before hospitalisation) of 0 * Stay \> 72 hours in another facility before admission to UGA * Opposition to participation in the study (trusted support person / guardian - curator) * Not affiliated to a social security scheme (beneficiary or beneficiary entitled) * Patient under AME

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for An acute pathology are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

acute disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

An acute pathology

Contacts and locations

Locations

  • Hôpital Pitié-Salpêtrière

    Paris, France